Thoratec reports positive trial results for heart pump

12/5/2008 | Reuters

Thoratec Corp. said an interim analysis of a Phase III trial of its HeartMate II showed that the device is statistically better than its other cardiac pump in treating patients who are ineligible for a transplant. The company plans to seek premarket approval from the FDA in the first half of next year to sell HeartMate II as a destination treatment.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC